Anzeige
Mehr »
Login
Sonntag, 15.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Der nächste MicroStrategy? Der Solana-Schachzug dieses Unternehmens ist UMWERFEND
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
531 Leser
Artikel bewerten:
(2)

Tribe Public LLC: Join (Sept. 17) "Nitric Oxide - From Viagra To COVID-19" By Nobel Prize Winner Dr. Lou Ignarro, Ph.D.

Finanznachrichten News

Meet Nobel Prize Winner Dr. Lou Ignarro, Ph.D. As He Presents "Nitric Oxide From Viagra To COVID-19"

SAN FRANCISCO, CA / ACCESSWIRE / September 15, 2020 / Tribe Pubic announced today that Nobel Prize Winner Dr. Lou Ignarro, Ph.D. will present at Tribe Public's Zoom Webinar Presentation and Q&A Event that is scheduled to begin at 8 am pacific/ 11 am eastern on Thursday, September 17, 2020. During this complimentary, 30-minute event, Dr. Ignarro will deliver his presentation "Nitric Oxide From Viagra To COVID-19" and be available for a Q&A session. To register to join the complimentary event, please visit the lou.tribepublic.com.

Dr. Lou Ignarro, Ph.D. Background
Dr. Ignarro won the Nobel Prize in medicine in 1998, along with Robert F. Furchgott and Ferid Murad, for his research discoveries showing the powerful ability of Nitric Oxide (NO) to support cardiovascular health. His groundbreaking work-the basis for his 2005 best-selling book, NO More Heart Disease-established him as perhaps the world's leading authority on nutritional approaches to cardiac wellness. He sits on the Herbalife Nutrition Advisory Board, which is composed of leading experts in the areas of health and nutrition. As part of his role with the organization, he also developed the formulation of the entire Herbalife cardio line. He spent more than 40 years as a research scientist, seeking to understand the incredible role that NO plays in fostering optimal health. One of his most important discoveries was that antioxidants increase NO levels by protecting blood vessel walls from damage. As co-author of The New Heart Health and the Health Is Wealth series, he refined his research on NO to help people live healthy, active lives and support heart health. He has a Ph.D. in pharmacology and is professor emeritus at UCLA, where he received 11 outstanding teacher awards voted by the medical students in the program. He is also a part-time professor at King Saud University in Riyadh, Saudi Arabia.

ABOUT TRIBE PUBLIC LLC
Tribe Public LLC is a San Francisco, CA-based organization that hosts complimentary worldwide webinar events & meeting events throughout the U.S. Tribe's complimentary events focus on issues that the Tribe members care about with an emphasis on hosting management teams from publicly traded companies from all sectors that are seeking to increase awareness of their products, progress, and plans. Tribe's members primarily include Family Offices, Portfolio Managers, Registered Investment Advisors, & Accredited Investors. Visit Tribe's Website to join today http://www.tribepublic.com. Forward any questions to Tribe's management at research@tribepublic.com.

CONTACT:
Tribe Public, LLC.
John F. Heerdink, Jr.
Managing Partner
john@tribepublic.com

SOURCE: Tribe Public LLC



View source version on accesswire.com:
https://www.accesswire.com/606121/Join-Sept-17-Nitric-Oxide--From-Viagra-To-COVID-19-By-Nobel-Prize-Winner-Dr-Lou-Ignarro-PhD

© 2020 ACCESSWIRE
5 heiße Wetten für den Jahresendspurt!
Nach dem unerwartet schnellen Ende der US-Wahlen mit dem Sieg des republikanischen Kandidaten Donald Trump fackelten die Aktien- und Krypto- Märkte ein wahres Kursfeuerwerk ab und bliesen zur Jahresendrallye.

Im aktuellen kostenlosen Report beleuchten wir 5 aussichtsreiche Unternehmen, die das Fundament besitzen, in den nächsten Monaten den breiten Markt zu schlagen.

Seien Sie dabei!

Fordern Sie jetzt unseren brandneuen neuen Spezialreport an und erfahren Sie, welche Aktien aufgrund ihrer Bewertung sowie charttechnischen Situation das Potenzial zu einer Outperformance besitzen.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.